financetom
Technology
financetom
/
Technology
/
PurpleLab Expands the Healthcare Advertising Ecosystem with Consecutive Strategic Partnerships
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PurpleLab Expands the Healthcare Advertising Ecosystem with Consecutive Strategic Partnerships
Sep 10, 2025 1:03 PM

The healthcare analytics company partnered with Experian, DeepIntent, InsightsRx, and Comscore to deliver scale, precision, privacy-conscious targeting, and real-time measurement for pharmaceutical advertisers.

PHILADELPHIA--(BUSINESS WIRE)--

PurpleLab®, the healthcare analytics company powering evidence-based decisions across life sciences, has announced a series of major partnerships with Experian, DeepIntent, InsightsRx, and Comscore. Together, these collaborations allow advertisers to use data in more innovative ways, ensuring advertising ROI.

Pharmaceutical advertising spend continues to rise, reaching $2.97 billion on national TV alone in the first half of 2025, a 12.2% year-over-year increase, according to eMarketer. With privacy regulations tightening, signal loss and walled gardens obscuring patient journeys, as well as increasing media fragmentation, brands need clinically precise data that can move seamlessly from discovery to delivery.

PurpleLab is meeting this demand by aligning its healthcare dataset with these leading partners to enhance the full marketing journey from activation to measurement. PurpleLab’s data has long been fit for purpose for clinical and commercial life science needs, with comprehensive claims data coverage of 330 million de-identified patients, 2.3 million providers, and more than eight billion claims annually. Additionally, investments in its data speed and applicability to clean room functions make it a standout partner to pharma marketers.

All launched within a single week, these strategic partnerships effectively close the loop on audience activation, media buying, and optimization for healthcare-specific targeting as well as results measurement, enabling advertisers to prove impact at all phases of a campaign.

“Healthcare advertising is evolving quickly, and marketers need privacy-centric audiences they can activate and measure with confidence,” said Scott Ronay, VP of Advertising Sales at PurpleLab. “These partnerships speak to the quality of PurpleLab’s audiences; by enabling our clients to reach their ideal target seamlessly across channels, we’re creating an ecosystem that helps advertisers drive results responsibly, better engaging providers, and ultimately improving health outcomes for patients.”

"Partnering with Experian, DeepIntent, InsightsRx, and Comscore marks an incredible milestone in our growth journey,” continued Ronay. “Each of these unions extends the reach and impact of our privacy-first healthcare data—whether it’s making our audiences more accessible through Experian’s marketplace, powering precision media buys with DeepIntent, enabling real-time optimization with InsightsRx, or delivering validated outcomes through Comscore. These collaborations reinforce our commitment to helping clients activate smarter, more efficient, results-driven campaigns. This momentum reflects the growing demand for trusted, scalable data solutions in healthcare, and we’re proud to be at the center of it."

Read more about each partnership:

PurpleLab Audiences Available in Experian’s Data Marketplace and Audigent PMPs

PurpleLab audiences are live in Experian’s Data Marketplace, enabling HIPAA-compliant targeting across CTV, mobile, display, and social. With Experian’s proven identity resolution capabilities, marketers can trust they’re reaching ideal and consistent audiences across CTV, mobile, and other channels, ensuring omnichannel tactics successfully engage the same, correct audiences with the full range of tactics.

As one of the first pharma-specific healthcare data sources available for Experian’s contextual targeting solutions via Audigent, PurpleLab is enabling advertisers to combine ideal audience segments with curated, brand-safe inventory. This partnership also sets the stage for future measurement capabilities, bringing more accountability to healthcare advertising.

Accelerating Smarter Targeting with DeepIntent

Giving healthcare marketers access to higher AQ audiences for improved performance, reach, and speed of delivery, PurpleLab audiences are now directly integrated into the DeepIntent Audience Marketplace, supporting rapid development and deployment of custom segments while maintaining even higher performance against industry benchmarks. Early tests have demonstrated that PurpleLab delivers larger, more accurate segments, driving 30% more verified patients, a 22% lift in audience quality, and a 5% increase in unique reach across therapeutic categories.

For clients, this means greater efficiency and less drop-off when onboarding. Campaigns will now reach more of the right patients and providers, with less waste and faster timelines, reducing friction between data and activation. By targeting smarter via PurpleLab, healthcare advertisers can deliver resonant messages when audiences are most receptive.

InsightsRx Is Transforming Pharma Media Optimization with Real-Time Measurement

PurpleLab has partnered with InsightsRx to help healthcare advertisers optimize campaigns in real-time. Traditionally, marketers wait months for ROI reports before adjusting spend, however, by combining PurpleLab’s prescription data with InsightsRx’s proprietary algorithms, brands can access actionable insights within weeks.

InsightsRx was built to help agencies and brand teams adjust HCP marketing in flight, determining which doctors to increase or decrease promotion to while campaigns are live. This collaboration replaces lagging indicators with proactive intelligence, giving marketers the agility to align campaigns more closely with patient and provider behavior as it unfolds.

Future-Proofing Audience Targeting with Comscore

PurpleLab has joined Comscore’s AI-powered Data Partner Network to extend its audiences into ID-free, privacy-centric segments. By transforming precise, ID-based datasets into scalable, predictive audiences, healthcare marketers can maintain precision and reach even as cookies and mobile IDs disappear.

With this integration, PurpleLab clients can activate tokenized condition-specific identity free segments across major DSPs and SSPs, ensuring their campaigns remain both compliant and effective as privacy regulations and technology standards evolve. If the future is cookieless, Comscore’s analytics and PurpleLab’s data will ensure it is still efficient.

About PurpleLab

PurpleLab® is a healthcare analytics company dedicated to driving value-driven innovation across the healthcare continuum. Its no-code analytics platform, HealthNexus®, empowers life sciences, payers, providers, advertisers, and other healthcare stakeholders to develop real-world evidence (RWE), demonstrating the effectiveness of novel therapeutics or clinical strategies in saving lives and reducing costs.

As one of the few CMS Qualified Entities, PurpleLab has access to Medicare claims data under Parts A, B, and D, enabling the evaluation of provider performance. The company is also a member of the Network Advertising Initiative (NAI), adhering to the highest standards for responsible data collection and usage in digital advertising. Additionally, PurpleLab holds HiTRUST certification, meeting the rigorous security and privacy requirements essential in healthcare data management.

For more information, visit purplelab.com.

Source: PurpleLab

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Behind the Scenes of IBM's Latest Options Trends
Behind the Scenes of IBM's Latest Options Trends
Nov 12, 2024
Investors with a lot of money to spend have taken a bullish stance on IBM ( IBM ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Nvidia and SoftBank pilot world's first AI and 5G telecom network
Nvidia and SoftBank pilot world's first AI and 5G telecom network
Nov 12, 2024
TOKYO, Nov 13 (Reuters) - Leading chipmaker Nvidia ( NVDA ) and SoftBank Corp ( SFTBF ), the telecommunications arm of SoftBank Group, have piloted the world's first artificial intelligence and 5G telecoms network, the two companies said on Wednesday. The network can run AI and 5G workloads concurrently, a process known as an artificial intelligence radio access network (AI-RAN),...
Deep Dive Into ServiceNow Stock: Analyst Perspectives (29 Ratings)
Deep Dive Into ServiceNow Stock: Analyst Perspectives (29 Ratings)
Nov 12, 2024
Ratings for ServiceNow ( NOW ) were provided by 29 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...
Behind the Scenes of ASML Holding's Latest Options Trends
Behind the Scenes of ASML Holding's Latest Options Trends
Nov 12, 2024
Deep-pocketed investors have adopted a bullish approach towards ASML Holding ( ASML ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ASML ( ASML ) usually suggests something big is about to happen. We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved